MBOT logo

MBOT
Microbot Medical Inc

17,727
Mkt Cap
$143.05M
Volume
962,779.00
52W High
$4.67
52W Low
$1.60
PE Ratio
-6.97
MBOT Fundamentals
Price
$2.13
Prev Close
$2.13
Open
$2.13
50D MA
$2.39
Beta
1.62
Avg. Volume
1.55M
EPS (Annual)
-$0.287
P/B
1.84
Rev/Employee
$0.00
$13.85
Loading...
Loading...
News
all
press releases
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday
Microbot Medical (NASDAQ:MBOT) will be releasing earnings after the market closes on Wednesday, May 13. (View Earnings Report at...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Cencora to Report Q2 Earnings: What's in Store for the Stock?
COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.
Zacks·5d ago
News Placeholder
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?
SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
Zacks·6d ago
News Placeholder
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.
Zacks·6d ago
News Placeholder
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.
Zacks·6d ago
News Placeholder
Revvity to Report Q1 Earnings: What's in Store for the Stock?
RVTY heads into Q1 earnings with Diagnostics strength and Life Sciences stabilization, but China pressures and weak academic demand may temper near-term growth.
Zacks·6d ago
News Placeholder
Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen
Wall Street Zen downgraded Microbot Medical from a "sell" rating to a "strong sell" rating in a research note on Saturday...
MarketBeat·9d ago
News Placeholder
Stryker to Report Q1 Earnings: What's in Store for the Stock?
SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.
Zacks·12d ago
News Placeholder
Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Microbot Medical Inc. (NASDAQ:MBOT - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are covering the stock, MarketBeat reports. One equities...
MarketBeat·15d ago
News Placeholder
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
DexCom's Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could weigh on margins.
Zacks·16d ago
<
1
2
...
>

Latest MBOT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.